/Companies

CrowdMed

DefunctYC W13

San Francisco, US · Founded 2012 · 5 employees · 15 known investors

Find your way into CrowdMed

Sign up to see every warm intro you have to CrowdMed

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the CrowdMed team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

CrowdMed connects patients with a community of medical experts ("Medical Detectives") to help solve complex, undiagnosed medical cases through crowdsourced diagnostic suggestions. Patients submit their medical history and symptoms, receive a report with top diagnostic recommendations, and can present these insights to their physicians for testing.

Also known as CrowdMed, Inc.

B2B MarketplacesDigital HealthHealthtechConsumer Health ServicesUnited States of AmericaAmerica / CanadaFully Remote

Founders & leadership· Y Combinator alumni (W13)

CrowdMed was founded in 2012 by Jared Heyman.

JHJared Heyman
Jared HeymanFounder & CEO2012–2018Jared Heyman is Managing Partner at Rebel Fund, a seed-stage venture fund focused on Y Combinator startups, and Executive Chairman of CrowdMed, an online medical diagnosis platform. He has held leadership roles at venture-backed technology companies.
DP
David Pervan, PhDCEO2020–2023

Investors · 15

Mindset Venturelisted by Mindset VentureSan Francisco · $500K – $3M

How we know: a partner's Signal profile · the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Brighteye VenturesreportedLondon

How we know: Y Combinator's founder network · Not right? Tell us

General CatalystreportedSan Francisco · $30M

How we know: Y Combinator's founder network · Not right? Tell us

Start Capitalreported

How we know: Y Combinator's founder network · Not right? Tell us

SV AngelreportedSan Francisco · $150K – $20M

How we know: Y Combinator's founder network · Not right? Tell us

Venture Investment AssociatesreportedPeapack

How we know: Y Combinator's founder network · Not right? Tell us

WefunderreportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

Company profile

researched Aug 2026

CrowdMed (CrowdMed, Inc.) was a San Francisco, California healthcare technology platform that applied crowdsourcing and prediction-market techniques to medical data in order to suggest diagnoses for difficult and undiagnosed cases. Patients completed an online questionnaire covering their medical history, current symptoms and personal circumstances, and submitted the case anonymously; profiles included symptoms, health history, family background and previous testing. A community of participants known as "medical detectives" then proposed possible diagnoses, which other detectives elaborated on. Contributions were weighted according to each detective's prior performance and patient ratings, and detectives could earn and share monetary rewards offered by patients for help solving a case. The top three diagnostic suggestions were compiled into a report for the patient to take to a physician for testing.

There was no requirement for a medical degree to participate as a medical detective; the community included medical students, retired physicians and lay contributors. The company positioned its service for individuals as well as insurance providers and self-insured corporate customers as a way to reduce healthcare costs. CrowdMed graduated from Y Combinator's Winter 2013 batch and launched publicly at the TEDMED 2013 conference in Washington, D.C. Its advisors included founders and executives of online healthcare companies such as WebMD. Y Combinator lists the company's status as inactive and its founders as former founders.

Founding story

Jared Heyman founded the company in 2012 with Axel Setyanto and Jessica Greenwalt after his sister struggled to obtain a diagnosis for her FXPOI condition. During development, the website was tested with 300 randomly selected people.

Business model

CrowdMed operated a consumer-facing subscription/case-submission service, marketed with a seven-day free trial and HSA/FSA eligibility, while also targeting insurance providers and self-insured corporate customers with the proposition of lowering healthcare spending. Medical detectives could earn and share monetary rewards put up by patients for solving their cases.

Paid patient case submissions with a seven-day free trial and stated HSA/FSA eligibility, alongside offerings aimed at insurance providers and self-insured employers.

Traction

More than 900 cases solved as of May 2015; users reported in 21 countries per Wikipedia, while the company's site cites patients in more than 30 countries and "12K happy customers." A January 2016 study in the Journal of Medical Internet Research examined nearly 400 cases from May 2013 to April 2015, finding roughly half of patients likely to recommend CrowdMed to a friend and about 60% reporting insights that moved them closer to a correct diagnosis.

Latest developments

Wikipedia reports the CrowdMed website has appeared down since October 16, 2023, and that the company's LinkedIn page indicated 10 employees as of September 2024; Y Combinator lists the company's status as inactive with a team size of 5. Founder Jared Heyman is described as Executive Chairman of CrowdMed and Managing Partner of Rebel Fund, a seed-stage venture fund investing in Y Combinator startups.

▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies

Market position

An early and widely covered example of crowdsourced medical diagnosis, backed by well-known Silicon Valley investors and a Y Combinator alumnus, operating in consumer health services.

Combined open, non-credentialed crowd participation with performance-weighted aggregation and prediction-market mechanics, and monetary case rewards, rather than relying on a closed panel of credentialed physicians.

Technology

An online case-submission questionnaire feeding a crowdsourcing platform that applied prediction-market technology to medical data, aggregating and weighting suggestions from many contributors based on their historical accuracy and patient ratings to produce a ranked list of diagnostic suggestions.

Go-to-market

Direct-to-consumer acquisition through its website with a free trial, amplified by a public launch at the TEDMED 2013 conference and extensive press coverage; the company also pitched insurers and self-insured employers as institutional buyers.

Patients with complex, undiagnosed or rare medical conditions, plus insurance providers and self-insured corporate customers; the case-solving side of the marketplace drew medical students, retired physicians and other lay participants.

Geography

Headquartered in San Francisco, California, with users internationally — 21 countries per Wikipedia and 30-plus countries per the company's website.

History

Founded in 2012, CrowdMed went through Y Combinator's Winter 2013 batch, raised $1.1 million and launched its public beta at TEDMED in Washington, D.C. in 2013. It went on to raise a total of $2.4 million in seed funding from investors including New Enterprise Associates, Andreessen Horowitz, Greylock Partners, SV Angel, Khosla Ventures, Y Combinator and actor Patrick Dempsey. By May 2015 the platform had solved more than 900 cases. Wikipedia reports the website appearing down from October 16, 2023, and Y Combinator lists the company as inactive.

Risks & controversies

Users and commentators raised concerns that information supplied through the platform may not come from reliable sources, given that medical detectives were not required to hold medical degrees; critical coverage appeared in the San Francisco Chronicle and KevinMD under framings such as "the dangers of crowdsourced medicine" and "the dangers of inexpert diagnosis from a noisy crowd." The January 2016 evaluation found only about half of patients would recommend the service. Y Combinator now lists the company as inactive and its website reportedly went down in October 2023.

Compiled by commissioned research from 5 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Cases solvedMay 2015900 cases
Countries served (company website)Jan 202530+
Countries with usersJan 201521
Customers (company website)Jan 202512K happy customers
Employees (LinkedIn page)Sep 202410 employees
Patients likely to recommend CrowdMed to a friendJan 201650%
Patients reporting insights that led closer to correct diagnosisJan 201660%
Subscription price (Basic plan)Jan 2025$4.95
Subscription price (Enterprise plan)Jan 2025$14.95
Subscription price (Professional plan)Jan 2025$9.95
Team size (Y Combinator listing)Jan 20255 employees
Total employees (Built In listing)Jan 202512 employees
Total funding raisedJan 2015$2.4M

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Related companies · 5

Jeevam HealthJeevam Health provides software that helps physicians diagnose underlying causes of thyroid dysfunction and develop treatment plans combining medication, nutrition, supplements, and lifestyle interventions for patients with persistent symptoms.
Gradia HealthGradia provides a virtual care platform for patients with chronic conditions, offering integrated communication and specialized care coordination between clinic appointments to supplement traditional in-person care.
ClinikallyClinikally develops and sells dermatology-backed skin and hair care products for Indian consumers, complemented by online consultations with dermatologists. The company formulates medical-grade products targeting specific skin and hair conditions using high-quality ingredients sourced from Europe and the USA, with efficacy validated through clinical studies.
RTHMRTHM combines artificial intelligence with clinical expertise to help patients with complex and unexplained illnesses find faster paths to diagnosis and treatment. The platform serves patients and healthcare providers within the digital health and diagnostics industry.
REPROSENTREPROSENT captures patient treatment experience data to support dose, safety, and development decisions in oncology and advanced cancer therapies. The platform operates as a lightweight, non-interventional overlay on existing clinical trials and care programs, converting patient symptoms into structured, computable signal for development and clinical teams.

Companies working in the same space as CrowdMed.

Timeline · 5

launches, deals, and filings
Oct 2023
Website reported down

Wikipedia states that since October 16, 2023 the CrowdMed website appears down; Y Combinator lists the company as inactive.

source ↗

May 2014
Actor Patrick Dempsey invests in CrowdMed

The Wall Street Journal reported that Patrick Dempsey invested in the health startup CrowdMed.

source ↗

Apr 2013
CrowdMed raises $1.1 million seed funding

Y Combinator-backed CrowdMed launched to crowdsource medical diagnoses with $1.1 million in funding, as reported by TechCrunch and Mobi Health News.

$1.1M source ↗

Jan 2013
Graduated from Y Combinator Winter 2013 batch

CrowdMed completed Y Combinator's Winter 2013 accelerator program.

source ↗

Jan 2013
Public beta launched at TEDMED 2013

CrowdMed launched its public beta at the TEDMED conference in Washington, D.C.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Legal entities · 1

corporate structure
CrowdMed, Inc.

▸Research sources · 5

primary sources listed

5 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does CrowdMed do?
CrowdMed was a San Francisco healthcare platform that crowdsourced diagnostic suggestions for difficult, undiagnosed medical cases.
Who founded CrowdMed?
CrowdMed was founded by Jared Heyman in 2012.
Who are CrowdMed's investors?
CrowdMed's investors include AAF Management Ltd., Mindset Venture, New Enterprise Associates (NEA), Y Combinator, Andreessen Horowitz, Brighteye Ventures, Emerson Collective Investing, General Catalyst and 7 more.
Where is CrowdMed headquartered?
CrowdMed is headquartered in San Francisco, US.